Soft-Tissue Metastases on FDG-PET in Advanced Prostate Cancer
Clinical Nuclear Medicine Open · 2025
DOI: 10.1097/nm9.0000000000000021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nuclear Medicine Open, 2025. Verfasst von Debra Ann Dawson und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
An 80-year-old man was found to have metastatic prostate carcinoma at the initial diagnosis. CT imaging revealed multiple large soft tissue masses in the neck, lungs, hila, mediastinum, retroperitoneum, peritoneum, and axillae, as well as multifocal bony lesions. An FDG-PET/CT was ordered to help clarify whether the thoracic findings were likely attributable to a synchronous lung malignancy. FDG-PET/CT images showed hypermetabolic soft tissue lesions, lymphadenopathy above and below the diaphragm, a left perihilar mass, and multiple skeletal metastases. Since the observed lesions showed similar metabolic activity as a biopsy-proven prostate metastasis, all metastatic involvement was favored secondary to prostate cancer.
Zitieren
APA
Dawson, D. A., & Rachinsky, I. (2025). Soft-Tissue Metastases on FDG-PET in Advanced Prostate Cancer. Clinical Nuclear Medicine Open. https://doi.org/10.1097/nm9.0000000000000021
Vancouver
Dawson DA, Rachinsky I. Soft-Tissue Metastases on FDG-PET in Advanced Prostate Cancer. Clinical Nuclear Medicine Open. 2025. doi:10.1097/nm9.0000000000000021
BibTeX
@article{Dawson2025,
author = {Dawson, Debra Ann and Rachinsky, Irina},
title = {Soft-Tissue Metastases on FDG-PET in Advanced Prostate Cancer},
journal = {Clinical Nuclear Medicine Open},
year = {2025},
doi = {10.1097/nm9.0000000000000021}
}
EUVIMED